Related Experiment Video
Updated: Jun 10, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects
Minh-Vu H Nguyen1, Michelle K Haas1,2, Shannon H Kasperbauer1
1Division of Mycobacterial and Respiratory Infections, Department of Medicine, National Jewish Health, Denver, Colorado, USA.
Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a growing global health challenge. This review simplifies NTM-PD management by outlining key principles for diagnosis and patient-centered, pathogen-directed therapy.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Nontuberculous mycobacterial pulmonary disease (NTM-PD) incidence is rising globally.
- Management of NTM-PD is complex due to over 190 NTM species requiring tailored multidrug regimens.
- Existing guidelines offer comprehensive evidence but the field's breadth remains challenging.
Purpose of the Study:
- To distill the complex field of NTM-PD into applicable principles.
- To provide clinicians and patients with a clearer understanding of NTM-PD management.
- To highlight key aspects including presentation, diagnosis, care principles, and future prospects.
Main Methods:
- Narrative review of current literature and guidelines.
- Synthesis of evidence-based information on NTM-PD.
- Focus on principles applicable across most NTM species.
Main Results:
- Established principles for patient-centered care in NTM-PD.
- Outlined principles for pathogen-directed therapy.
- Detailed presentation and diagnostic considerations for NTM-PD.
Conclusions:
- Simplifying NTM-PD management through core principles is crucial.
- Patient-centered care and pathogen-directed therapy are vital for effective NTM-PD treatment.
- Further advancements are needed to address the complexity of NTM-PD.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

